NDC 23731-6051

Anticoagulant Citrate Dextrose A

Anhydrous Citric Acid, Dextrose Monohydrate, And Trisodium Citrate Dihydrate

Anticoagulant Citrate Dextrose A is a Extracorporeal Solution in the Human Prescription Drug category. It is labeled and distributed by Citra Labs. The primary component is Dextrose Monohydrate; Anhydrous Citric Acid; Trisodium Citrate Dihydrate.

Product ID23731-6051_663761c2-0c5c-9ea5-e053-2a91aa0ad87f
NDC23731-6051
Product TypeHuman Prescription Drug
Proprietary NameAnticoagulant Citrate Dextrose A
Generic NameAnhydrous Citric Acid, Dextrose Monohydrate, And Trisodium Citrate Dihydrate
Dosage FormSolution
Route of AdministrationEXTRACORPOREAL
Marketing Start Date2003-08-26
Marketing CategoryNDA / NDA
Application NumberBN020037
Labeler NameCitra Labs
Substance NameDEXTROSE MONOHYDRATE; ANHYDROUS CITRIC ACID; TRISODIUM CITRATE DIHYDRATE
Active Ingredient Strength0 g/10mL; g/10mL; g/10mL
Pharm ClassesAcidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 23731-6051-1

10 VIAL, SINGLE-USE in 1 CASE (23731-6051-1) > 30 mL in 1 VIAL, SINGLE-USE (23731-6051-3)
Marketing Start Date2003-08-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 23731-6051-2 [23731605102]

Anticoagulant Citrate Dextrose A SOLUTION
Marketing CategoryNDA
Application NumberBN020037
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-03-06

NDC 23731-6051-1 [23731605101]

Anticoagulant Citrate Dextrose A SOLUTION
Marketing CategoryNDA
Application NumberBN020037
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-03-06

NDC 23731-6051-5 [23731605105]

Anticoagulant Citrate Dextrose A SOLUTION
Marketing CategoryNDA
Application NumberBN020037
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2003-08-26
Marketing End Date2015-03-06

NDC 23731-6051-3 [23731605103]

Anticoagulant Citrate Dextrose A SOLUTION
Marketing CategoryNDA
Application NumberBN020037
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-03-06

Drug Details

Active Ingredients

IngredientStrength
DEXTROSE MONOHYDRATE.245 g/10mL

OpenFDA Data

SPL SET ID:5bcd261e-ebba-4ecb-af22-e5aaeb04499b
Manufacturer
UNII

Pharmacological Class

  • Acidifying Activity [MoA]
  • Calculi Dissolution Agent [EPC]
  • Anti-coagulant [EPC]
  • Decreased Coagulation Factor Activity [PE]
  • Calcium Chelating Activity [MoA]
  • Acidifying Activity [MoA]
  • Calculi Dissolution Agent [EPC]
  • Anti-coagulant [EPC]
  • Decreased Coagulation Factor Activity [PE]
  • Calcium Chelating Activity [MoA]
  • Acidifying Activity [MoA]
  • Calculi Dissolution Agent [EPC]
  • Anti-coagulant [EPC]
  • Decreased Coagulation Factor Activity [PE]
  • Calcium Chelating Activity [MoA]
  • Acidifying Activity [MoA]
  • Calculi Dissolution Agent [EPC]
  • Anti-coagulant [EPC]
  • Decreased Coagulation Factor Activity [PE]
  • Calcium Chelating Activity [MoA]

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.